MYCN and neuroblastoma: The GSE3960 and GSE85047 microarray datasets, containing 102 samples among which 20 were MYCN amplified (GSE3960; ref. 24), or 283 primary neuroblastoma of which 55 were MYCN amplified (GSE85047), were used to test our findings.